Flputnam Investment Management Co. Sells 7,574 Shares of The Clorox Company $CLX

Flputnam Investment Management Co. reduced its stake in shares of The Clorox Company (NYSE:CLX) by 55.6% in the fourth quarter, according to its most recent filing with the SEC. The fund owned 6,060 shares of the company’s stock after selling 7,574 shares during the period. Flputnam Investment Management Co.’s holdings in Clorox were worth $611,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Center for Financial Planning Inc. purchased a new position in Clorox in the 3rd quarter worth $25,000. Vermillion & White Wealth Management Group LLC purchased a new position in Clorox in the 3rd quarter worth $25,000. Darwin Wealth Management LLC purchased a new position in Clorox in the 2nd quarter worth $29,000. Vision Financial Markets LLC raised its position in Clorox by 166.7% in the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, Ameriflex Group Inc. raised its position in Clorox by 1,436.8% in the 3rd quarter. Ameriflex Group Inc. now owns 292 shares of the company’s stock worth $36,000 after purchasing an additional 273 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

CLX stock opened at $89.98 on Friday. The firm’s 50-day moving average price is $98.46 and its two-hundred day moving average price is $105.81. The Clorox Company has a 12-month low of $84.70 and a 12-month high of $132.03. The stock has a market capitalization of $10.88 billion, a price-to-earnings ratio of 14.61, a PEG ratio of 0.50 and a beta of 0.59. The company has a current ratio of 0.84, a quick ratio of 0.65 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion for the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the company earned $1.45 earnings per share. The company’s revenue for the quarter was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities analysts predict that The Clorox Company will post 5.61 earnings per share for the current year.

Analyst Ratings Changes

CLX has been the topic of a number of analyst reports. Rothschild & Co Redburn set a $117.00 target price on shares of Clorox in a research report on Friday, February 13th. Wall Street Zen upgraded shares of Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Jefferies Financial Group decreased their target price on shares of Clorox from $139.00 to $125.00 and set a “buy” rating on the stock in a research report on Monday, May 4th. Royal Bank Of Canada decreased their target price on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating on the stock in a research report on Thursday, April 9th. Finally, Morgan Stanley decreased their target price on shares of Clorox from $110.00 to $97.00 and set an “equal weight” rating on the stock in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have given a Hold rating and five have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company presently has an average rating of “Reduce” and a consensus price target of $103.40.

Insider Activity at Clorox

In other Clorox news, Director Pierre R. Breber purchased 5,000 shares of the company’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average price of $85.82 per share, with a total value of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at $1,544,760. The trade was a 38.46% increase in their position. The purchase was disclosed in a filing with the SEC, which is available at this hyperlink. 0.63% of the stock is currently owned by corporate insiders.

Clorox Company Profile

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.